JP2025515092A5 - - Google Patents
Info
- Publication number
- JP2025515092A5 JP2025515092A5 JP2024564920A JP2024564920A JP2025515092A5 JP 2025515092 A5 JP2025515092 A5 JP 2025515092A5 JP 2024564920 A JP2024564920 A JP 2024564920A JP 2024564920 A JP2024564920 A JP 2024564920A JP 2025515092 A5 JP2025515092 A5 JP 2025515092A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- antibody
- acid sequence
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263337941P | 2022-05-03 | 2022-05-03 | |
| US63/337,941 | 2022-05-03 | ||
| US202263340909P | 2022-05-11 | 2022-05-11 | |
| US63/340,909 | 2022-05-11 | ||
| PCT/US2023/065591 WO2023215674A1 (en) | 2022-05-03 | 2023-04-10 | Methods for treating lymphoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025515092A JP2025515092A (ja) | 2025-05-13 |
| JP2025515092A5 true JP2025515092A5 (https=) | 2026-04-17 |
Family
ID=86378472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024564920A Pending JP2025515092A (ja) | 2022-05-03 | 2023-04-10 | リンパ腫の処置方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250388691A1 (https=) |
| EP (1) | EP4518975A1 (https=) |
| JP (1) | JP2025515092A (https=) |
| KR (1) | KR20250019746A (https=) |
| CN (1) | CN119546335A (https=) |
| AU (1) | AU2023264582A1 (https=) |
| CA (1) | CA3256548A1 (https=) |
| CL (2) | CL2024003328A1 (https=) |
| IL (1) | IL316747A (https=) |
| MX (1) | MX2024013531A (https=) |
| WO (1) | WO2023215674A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5635517B1 (en) | 1996-07-24 | 1999-06-29 | Celgene Corp | Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines |
| BR112017023943A2 (pt) * | 2015-05-08 | 2018-07-31 | Xencor, Inc. | anticorpos heterodimêricos que ligam cd3 e antígenos de tumor |
| WO2018002031A1 (en) * | 2016-06-27 | 2018-01-04 | Morphosys Ag | Anti-cd19 antibody formulations |
| CN112794916B (zh) * | 2021-04-08 | 2021-08-10 | 正大天晴药业集团南京顺欣制药有限公司 | 三特异性抗原结合构建体及构建方法和应用 |
-
2023
- 2023-04-10 AU AU2023264582A patent/AU2023264582A1/en active Pending
- 2023-04-10 KR KR1020247040022A patent/KR20250019746A/ko active Pending
- 2023-04-10 WO PCT/US2023/065591 patent/WO2023215674A1/en not_active Ceased
- 2023-04-10 US US18/862,319 patent/US20250388691A1/en active Pending
- 2023-04-10 IL IL316747A patent/IL316747A/en unknown
- 2023-04-10 EP EP23723774.8A patent/EP4518975A1/en active Pending
- 2023-04-10 CA CA3256548A patent/CA3256548A1/en active Pending
- 2023-04-10 CN CN202380050611.4A patent/CN119546335A/zh active Pending
- 2023-04-10 JP JP2024564920A patent/JP2025515092A/ja active Pending
-
2024
- 2024-10-30 CL CL2024003328A patent/CL2024003328A1/es unknown
- 2024-10-31 MX MX2024013531A patent/MX2024013531A/es unknown
-
2025
- 2025-03-11 CL CL2025000684A patent/CL2025000684A1/es unknown